Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
9.06
+0.01 (0.11%)
At close: Jun 12, 2026, 4:00 PM EDT
9.14
+0.08 (0.88%)
After-hours: Jun 12, 2026, 7:16 PM EDT
Phreesia Revenue
Phreesia had revenue of $130.94M in the quarter ending April 30, 2026, with 12.94% growth. This brings the company's revenue in the last twelve months to $495.59M, up 14.05% year-over-year. In the fiscal year ending January 31, 2026, Phreesia had annual revenue of $480.59M with 14.48% growth.
Revenue (ttm)
$495.59M
Revenue Growth
+14.05%
P/S Ratio
1.13
Revenue / Employee
$277,021
Employees
1,789
Market Cap
560.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2026 | 480.59M | 60.78M | 14.48% |
| Jan 31, 2025 | 419.81M | 63.51M | 17.83% |
| Jan 31, 2024 | 356.30M | 75.39M | 26.84% |
| Jan 31, 2023 | 280.91M | 67.68M | 31.74% |
| Jan 31, 2022 | 213.23M | 64.56M | 43.42% |
| Jan 31, 2021 | 148.68M | 23.89M | 19.15% |
| Jan 31, 2020 | 124.78M | 24.90M | 24.92% |
| Jan 31, 2019 | 99.89M | 20.06M | 25.12% |
| Jan 31, 2018 | 79.83M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evolent Health | 1.89B |
| Claritev | 978.76M |
| GoodRx Holdings | 787.89M |
| Certara | 419.75M |
| TruBridge | 345.90M |
| HealthStream | 311.78M |
| Weave Communications | 248.72M |
| Talkspace | 238.37M |
PHR News
- 10 days ago - PHR Stockholders Have Rights – If You Lost Money Investing in Phreesia, Inc. Contact Robbins LLP for Information About Recovering Your Losses - Business Wire
- 16 days ago - Phreesia downgraded to Neutral from Overweight at Piper Sandler - TheFly
- 16 days ago - Phreesia downgraded to Neutral at Piper on lack of growth visibility - TheFly
- 17 days ago - Phreesia price target lowered to $16 from $22 at Canaccord - TheFly
- 17 days ago - Phreesia price target raised to $12 from $10 at Citi - TheFly
- 17 days ago - Phreesia affirms FY27 revenue view of $510M-$520M, consensus $515.7M - TheFly
- 17 days ago - Phreesia up 12% at $10.21 after Q1 results, affirmed guidance - TheFly
- 17 days ago - Phreesia Earnings Call Transcript: Q1 2027 - Transcripts